Mannkind (MNKD) FCF Margin Growth (5y) (2017 - 2026)
Mannkind (MNKD) FCF Margin Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,748.00 |
| Dec 31, 2025 | -550.00 |
| Sep 30, 2025 | 11,724.00 |
| Jun 30, 2025 | 192,724.00 |
| Mar 31, 2025 | 6,147.00 |
| Dec 31, 2024 | 6,186.00 |
| Sep 30, 2024 | 768,706.00 |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 7,436.00 |
| Dec 31, 2023 | -11,743.00 |
| Sep 30, 2023 | 32,713.00 |
| Jun 30, 2023 | 71,602.00 |
| Mar 31, 2023 | 60,721.00 |
| Dec 31, 2022 | 65,562.00 |
| Sep 30, 2022 | 105,191.00 |
| Jun 30, 2022 | 75,412.00 |
| Mar 31, 2022 | -43,808.00 |
| Dec 31, 2021 | -472.00 |
| Sep 30, 2021 | -4,952.00 |
| Sep 30, 2017 | 9.71 Mn |